Clinical Trial Update: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating different doses of methotrexate for meningeal carcinomatosis; the current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningeal Carcinomatosis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hui Bu | Conditions: Meningeal Carcinomatosis | Phase 4 | Status: UNKNOWN